Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:23:45.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision (v3.3.2) has been added to the record history, and the previous revision (v3.3.1) has been removed.
    Difference
    0.1%
    Check dated 2025-12-01T16:09:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision history now lists a new version entry v3.3.1 and removes v3.2.0, representing a minor administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:12:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The government funding status banner was removed from the page; it was a general site-wide notice and does not affect study details or records. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:28:21.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Record History shows updates to Study Status and Recruitment Status across versions, indicating changes in the trial's activity and enrollment status.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:08.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Release 3.2.0 includes a prominent government funding/operating status notice and updates the version from 3.1.0 to 3.2.0.
    Difference
    13%
    Check dated 2025-10-05T09:56:57.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.